SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001013594-18-000381
Filing Date
2018-06-11
Accepted
2018-06-11 10:35:24
Documents
2

Document Format Files

Seq Description Document Type Size
1 JUNE 6, 2018 catalystb13g-060618.htm SC 13G 89998
2 JOINT FILING AGREEMENT catalystbex991-060618.htm EX-99.1 7129
  Complete submission text file 0001013594-18-000381.txt   98675
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655
CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-82442 | Film No.: 18891221
SIC: 2834 Pharmaceutical Preparations

Mailing Address 900 THIRD AVENUE SUITE 1100 NEW YORK NY 10022
Business Address 900 THIRD AVENUE SUITE 1100 NEW YORK NY 10022 (212) 213-7033
NEXTHERA CAPITAL LP (Filed by) CIK: 0001646343 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G